X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with K.S.Oils Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs K.S.OILS LTD - Comparison Results

K.S.OILS LTD 
   Change

K S Oils (KSO), established in 1985, with crushing capacity of 1,475 metric tones per day of mustard seeds is one of the largest manufacturers of mustard oil in India. It enjoys a 4.5% share of total mustard oil market with a dominant 25% market shar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES K.S.OILS LTD AMAR REMEDIES/
K.S.OILS LTD
 
P/E (TTM) x -0.5 -0.1 - View Chart
P/BV x 0.1 0.2 28.5% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 AMAR REMEDIES   K.S.OILS LTD
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
K.S.OILS LTD
Dec-12
AMAR REMEDIES/
K.S.OILS LTD
5-Yr Chart
Click to enlarge
High Rs16423 716.2%   
Low Rs864 2,205.1%   
Sales per share (Unadj.) Rs261.675.6 346.1%  
Earnings per share (Unadj.) Rs17.4-29.3 -59.4%  
Cash flow per share (Unadj.) Rs22.3-27.2 -82.1%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs100.72.1 4,835.0%  
Shares outstanding (eoy) m26.16459.18 5.7%   
Bonus/Rights/Conversions -PP-  
Price / Sales ratio x0.50.2 269.5%   
Avg P/E ratio x7.2-0.5 -1,569.4%  
P/CF ratio (eoy) x5.6-0.5 -1,136.8%  
Price / Book Value ratio x1.26.4 19.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m3,2706,153 53.1%   
No. of employees `000NA0.7 0.0%   
Total wages/salary Rs m163338 48.2%   
Avg. sales/employee Rs ThNM50,300.6-  
Avg. wages/employee Rs ThNM489.9-  
Avg. net profit/employee Rs ThNM-19,473.0-  
INCOME DATA
Net Sales Rs m6,84434,707 19.7%  
Other income Rs m2171 29.5%   
Total revenues Rs m6,86534,779 19.7%   
Gross profit Rs m1,131-5,731 -19.7%  
Depreciation Rs m128965 13.3%   
Interest Rs m3984,417 9.0%   
Profit before tax Rs m626-11,041 -5.7%   
Minority Interest Rs m022 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-2,277 2.2%   
Tax Rs m121140 86.6%   
Profit after tax Rs m455-13,436 -3.4%  
Gross profit margin %16.5-16.5 -100.1%  
Effective tax rate %19.3-1.3 -1,527.7%   
Net profit margin %6.6-38.7 -17.2%  
BALANCE SHEET DATA
Current assets Rs m4,90420,418 24.0%   
Current liabilities Rs m3,58117,967 19.9%   
Net working cap to sales %19.37.1 273.8%  
Current ratio x1.41.1 120.5%  
Inventory Days Days124109 114.0%  
Debtors Days Days10081 123.7%  
Net fixed assets Rs m1,68911,828 14.3%   
Share capital Rs m2623,058 8.6%   
"Free" reserves Rs m2,358-2,843 -82.9%   
Net worth Rs m2,635957 275.5%   
Long term debt Rs m50712,919 3.9%   
Total assets Rs m6,86233,013 20.8%  
Interest coverage x2.6-1.5 -171.5%   
Debt to equity ratio x0.213.5 1.4%  
Sales to assets ratio x1.01.1 94.9%   
Return on assets %12.4-27.3 -45.5%  
Return on equity %17.3-1,404.6 -1.2%  
Return on capital %31.0-64.0 -48.4%  
Exports to sales %4.00 15,213.6%   
Imports to sales %00-   
Exports (fob) Rs m2739 3,000.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m27345 613.5%   
Fx outflow Rs m218 11.4%   
Net fx Rs m27127 1,007.4%   
CASH FLOW
From Operations Rs m-313-97 323.5%  
From Investments Rs m-489676 -72.3%  
From Financial Activity Rs m769-603 -127.4%  
Net Cashflow Rs m-33-24 134.3%  

Share Holding

Indian Promoters % 25.5 9.1 280.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 9.2 0.5 1,840.0%  
FIIs % 0.0 3.2 -  
ADR/GDR % 0.0 10.5 -  
Free float % 65.3 76.7 85.1%  
Shareholders   13,061 139,498 9.4%  
Pledged promoter(s) holding % 99.7 100.0 99.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   HUL  EMAMI LTD  ARCHIES LTD  COLGATE  BAJAJ CONSUMER CARE  

Compare AMAR REMEDIES With:   UNILEVER PLC. (UK)  P&G (US)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Ends 160 Points Higher; IT and Healthcare Stocks Witness Buying(Closing)

Indian share markets traded on a positive note most of the day and ended higher. Gains were largely seen in the IT sector and healthcare sector, while capital goods stocks witnessed selling pressure.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

I Believe this is the Best Stock to Buy Today(Profit Hunter)

Jul 3, 2019

The languishing small cap space is currently offering a very fertile market to pick up bargains at very attractive prices. This is a perfect opportunity ripe for the picking.

This Smallcap Stock could be the next Page Industries(Profit Hunter)

Jul 2, 2019

The smallcap rebound is taking longer to play out...and that's good news as it gives you more of action time and opportunities to invest in.

The Indian Rating Agency Cleanup Has Begun and this Cheap Stock Could be the Best Bet(The 5 Minute Wrapup)

Jul 2, 2019

The last time this big rating agency was as cheap and out-of-favour as it is today, the stock had corrected by 40% in six months.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES - MARICO COMPARISON

COMPARE AMAR REMEDIES WITH

MARKET STATS